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Human mast cell precursors arise in the bone nlarrow 
and circulate to different tissue luicroenvironments, 
where they develop distinct phenotypes that may be 
characterized by differential expression of the serine 
protease, chymase. The growth and development of 
luast cells is stimulated by mast cell growth factor, 
which is also known as kit ligand because its obligate 
receptor is KIT, the protein product of the c-KIT 
proto-oncogene. The ill vivo influence of the KIT-kit 
ligand axis on the phenotype of hum all mast cells has 
not been determined. We used immunohistochemis-
try to detect ill s itu expression of tryptase and chy-
mase by mast cells of a patient with urticaria pigmen-
tosa and aggressive systeJUic mastocytosis, whose 
M ast cell s are derived from pluripotent CD34 + progenitor cells that originate in the bone mar-row an d circulate at low levels in the periphera l blood (Kirshenbaum el (/1, 1991, 1992). Mast cells proliferate and develop in different ti ssue 
microenvirOlun ents under the influence of a varie ty of £1ctors (Aloe 
and Levi-Montalcini, 1977; Nakano el at, 1985; Tsai el ai, 199 1; 
Kirshenbaum e/ aI, 1992; Longl ey CI nl, 1993) . One of these factors 
is mast ceJJ growth factor, which is also known as kit ligand because 
it is tbe obliga te ligand for KIT, the protein product of the c-KIT 
prow-on cogene (Anderson el ai , 1990; Huang el ai, 1990; Zsebo cl 
ai, 1990; Mitsui cl (/1, 1993). The KlT protein is a type III receptor 
tyrosine kinase expressed by mast cells and mas t cell progeni tors, 
and it stimulates mast cell growth , development, and differentiated 
functions in cluding secretion (Anderson cl ai, 1990; Zsebo el ai, 
1990; Tsai ct nl, 1991; Columbo el ai, 1992; Mitsui el ai, 1993; Spen 
CI ai , 1993). 
Mast cell s of humans and anim als exhibi t heterogeneity of a 
number of phenotypi c characteristics that may be correlated with 
their anatomic location and fun ction al sta te (Gall i, 1990; Longley el 
~ 1. 1995). T hese characteristics include their response to various 
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pathologic nlast cells are c10nally derived and chron, 
icaUy stimulated by KIT because they all contain the 
same point mutation causing constitutive activation. 
of KIT. Mast cells in both spleen and skin expressed 
tryptase, but only in the skin did a majority of mast 
cells express chymase. We conclude that chronic 
stimulation of the KIT -kit ligand axis does not irre. 
vocably commit mast cells to a chYJUase-positive Ot 
chymase-negative phenotype. These findings sug. 
gest that factors other than kit ligand predoJUinate 
in determining mast cell phenotype. Key words: llrasi 
cell heterogeltei tylch]' ilia sel c-KIT I mastocJ' tos isl IIIlItatio 111011-
cogene. ] Invest Dennotol 108:792-796, 1997 
hi stochemical stain s (Ma},:lmow, '1905; Hardy and Westbrook. 
1985; Enerback, 1986), the ultrastructural fea tures of their cyto-
plasmic granules (Cra ig et ai, 1988; Weidner and Austen , 1990), 
and the types of neutral proteases present within those granules 
(Irani et ai, 1986) . Two neutral proteases found in mast cell 
granules, tryptase and chymase, appear to be useful markers of 
different human mast cell sub rypes (Craig Ifl ai, 1986; Irani el al. 
1986). Essentially all mature human m ast cells produce tlyp tase 
(Irani el ai , 1986; Schwartz ci ai , 1987; C raig et ai, 1988), but only 
3 subpopulation of mast cells contain ch ymase (Irani e/ ai, 1986; 
Craig el nl , 1988). HUl11;m mast cells containing only t11'ptase 
ha ve been call ed M CT , and those containing both enzymes (chy-
mase and tryptase) have been designa ted M C eT (I1'ani eJ ai, 198 6). 
Whether kit ligand and other substances present in the micro-
en vi ronment act on cells that are already committed to a 
particular phenotype or playa role in commitment to a particular 
phenotype (if sl1 ch a commitment exists) ha s not been definitively 
determined . 
We recently id entified a clonal proliferation of mast cells present 
in bo th th e skin and spleen of a patient with adult-onset urticaria 
pigmcntosa and systemic m astocytos is (Longley et ai , 1996). In ch~ 
swd y reported herein, we sh ow that although the neoplastic ma t 
cells in this patient aJl contain a point mutation of the c-KIT 
proto- oncogene that is known to cause constitutive activation of 
IUT , the m,lst cells show heterogeneity in their expression of 
chym 3se in the different tisSLle microenvironm ents of skin and 
spleen . This demonstra tes that human clonally derived mast ceHs 
can exhibit heterogenei ry ill situ with respect to seline proteas 
production , and it shows chat chroni c stimulation via the KIT-kit 
0022- 202X/97 IS l 0.50 • Copyright '.1997 by The Society for Investiga ti ve Dermato logy, Inc. 
792 
VOL. 108. NO. M AY 199 7 
ligand axis does not cause permanent commitment to a particular 
mast cell phenotype. 
MATERlA.LS AND METHODS 
Inullunohistochemistry Fresh tissue samples of skin and sp leen were 
obtained from a 47-y-old man with a 7-y histo,)' of progressive urticaria 
pigmentosi' and a 5-y history of progressive splenomegaly with hyper-
splenism. Sa mples of sp leen and skin were snap-frozen in OCT embedding 
compound (Tissue-Tek, Miles Inc., Elkhart, IN) and liquid rtitrogen , and 
4-J.tm thick fi'ozen sections cut and mounted on Probe-on glass slides (Fisher 
Scientific, Pittsburgh , PAl. lrnmunoalkilline phosphatase sta ining fo r 
tryptase and chymase were performed using the Fisher Biotech Microprobe 
System and the APAAP detection system (Dako, Carpinteria, CAl using 
nitro blue tetrazolium/ 5-bromo-4-chloro-3-indolyl phosphate as chrollla-
gen and nuclear Fast I<..ed as a counterstain . T he primary anti-tryptase and 
anri- cbymase antibodies were murine monoclonal IgGI antibodies purified 
from ascites (Chemicon Ill te rnarionallnc., Temecula, CAl, and used at 1 fLg 
per rnl. Incubation was for 1 h at room temperature. 
Transmission Electron Microscopy Electron microscopy was per-
forITled on sp lenic tissue extracted fro m parafrin. Appropriate areas were 
excised and placed at 57°C for 30 mill in xylene. The tissue was transferred 
to fresh xylene at room temperature (X2), rehydrated through graded 
alcohols fi'om 100% ethanol to 50% ethanol, and washed ill 0.1 M 
cacodylatc buffer, pH 7.4, before being placed in 2.5% glutaraldehyde 
overnight at 4°C. The tissue was further processed by post-fixation in 2% 
osmi um , dehydrated, and embedded ill Taab Epon 812 (Marivac Ltd .. 
Halifax, Nova Scotia, Canada). Ultrathin sections were cut 011 a LKB 
Ultrotome III (LKB Instruments . . R.ockville, MD) , post-stained with uranyl 
acetate and bismuth subnitrate , and viewed with a Hitachi 7000 electron 
microscope (Hitachi Instruments, Inc., Elmsford, NY) . 
Sequence Analysis ltNA was extracted from six 20-fLm thick cryostat 
secrions of frozen spleen and skin using guanidiu l11 (Longley ci ai, :t 991). 
The RNA was treated with heparinase, 1 unit I<..NA per fLg (Sigma 
Chenlical Company. St. Louis, MO) for 2 h at room temperature (Tsai el ai , 
1995) before being revcrse transcribed using random hexamers (2.5 pmol/ 
iJ.l) and M-M u LV reverse transcriptase (R. T) (Boehringer Mannheil11, 
Inctianapolis, IN). Polymerase chain reaction (PCR.) was then performed 
wi th ArnphiTaq (Perkin-Elmer, Norwalk, CT) using primers corresponding 
to bases 2013- 2035 (5' GCCCACCCTGGTCATTACAGAAT) and 2594 -
257 5 (5' AAAATCCCATAGGACCAGAC) ofc- KIT (Yard en el al. 1987) 
for 40 cycles for 1. min denaturation, 1. min annealing at 52°C, and 1 min 
extensio'n at 72°C. Sequencing was carried out in the \Y.!. M. Keck 
Biotechnology R.esource Laboratory at Yale University using individual 
cDNAs subcloned from multiple independent R.T-PCI<..s as well as using 
gel-purified amplimers. Direct amplimer sequencing of genomic DNA 
derived £i'om the patient by buccal wash was performed after PCI<.. 
amplification of a portion of exon 17 of c-KIT, using primers flanking 
position 2468 (5' TGTATTCACAGAGACTIGGC; 5' GTTTCCTTT A-
ACCACATAA T corresponding to bases 2383-2402 and 2505-2486) (Lon-
gley el ai, 1991). 
RESULTS 
Splenic Mast Cells Express Tryptase but not Chymase 
Routine histology showed mast cells infiltrating the dennis in the 
skin samples and inftltrating the periarteriolar areas of the spleen , 
where there was extensive fibrosis with m any of the mast cells 
assUlning a spindled morphology (Fig 1). Increased numbers of 
mast cells were seen scattered about the red pulp as well. Immu-
no alkaline phosphatase staining showed tryptase but not chymase 
expressed by most of the mast cells in the spleen (Fig 2). Both 
irrunul10reactive chymase and tryptase, however, were associated 
with the mast cell s infiltrating the skin (Fig 3) . Both tryptase and 
chYlTIase were also present extracellularly in the vicinity of mast 
ceils, perhaps reflecting mast cell degranulation and release of 
granule proteases. Essentially all of the mast cells inftltrating the 
skin and spleen also express KIT (data not shown) . 
Splenic Mast Cells Show Ultrastructural Features of 
"Tryptase Only" Mast Cells Splenic tissue that had been fixed 
in formalin and embedded in parafrin was the only material 
available for electron microscopic study in this case. Mast cells and 
mast cell g ranules were eas ily identified, and the majority of the 
granules showed scrolls associated with an amorphous, variably 
electron-den se m atrix (Fig 4). These findin gs are consistent w ith 
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Figure 1. Mast cells infiltrate the spleen. Giems" stain shows that mOst 
of the spindle- and polygonal-sh"ped cells within the fib rotic area of the 
sp leen are mast ce ll s. Scale bar, 50 fLlll. 
the less than optimal preservation of mast cell granules containing 
only tryptase, or w ith the presence of granules containing both 
tryptase and chym ase . Many of the m ast cells, however, showed a 
spectrum of granule substructures including both small and large 
g ranules and rope-like configurations, ch aracteristic of MCT gran-
ule solubilization and partial degranulation (Mirowski el aI, 1.990) . 
Copy DNA Sequencing Shows Activating c-KIT Mutations 
in Skin and Spleen Sequencing of individual RT-PCR-derived 
cDNAs, subclo ned independently from both skin and spleen , 
identified a transition point mu tation (A -,> T) in exon 17 at 
position 2468, as well as the normal (nonmutated, wild type) 
sequence (Fig 5). Scqllcncin g of R T -PCR amplimers showed 
approx:imately equal representation of A and T at this position. 
Because these are RT -PCR-derived products, and because the v ast 
majority of the cells expressing KIT in these samples are mast cells, 
it appears the m as t ce ll s in this patient contain one mutated and one 
wild type c-KIT allele. Sequencin g of genomic DNA amplifi ed 
from non-mast cell leukocytes and oral epithelia l cell s showed a 
normal (nonmu tated, wild type) sequence (data not shown). These 
results indicate that the mu tation is a somatic mutation, speciJlcally 
expressed by mast cell s in this patient. Since m ast ce lls at both 
anatomic sites express the sam e mutation , they must all be derived 
from the sam e clone of chronically IGT-stimulated cells. 
DISCUSSION 
O ur immunohistochemical studies identify both chymase and 
tryptase expression by essen t.ially all of tile mast cells in this skin 
lesion of mastocytosis, confirming a previolls study sh owing a 
MCcT phenotype for mast cell s in cutaneous m astocytosis (Irani er 
aI, 1990). In the spleen, h owever, the vast majority of mast cells h ad 
a MCT pheno type by immunohistochemistry expressing only 
tryptase. T here are several ul trastructural features tha t suppOrt thi 
immunohistochemical phenotype of the spleni c ce lls. First, there 
was at least focal preservation of well-formed scro.lls witlun gran-
ules, consistent Witll the MC" phenotype. Second , w hereas l\1CC T 
type granules tend to show less heterogeneity during solubilization, 
the splenic mast cells showed a spectrum of degranulation within 
individual cells, typical of MCT type granu les (Mirowski er ai, 
1990). T hird , the rope-like configurations observed in the spl eni c 
m ast cells of this patient are usually associated with degranulation of 
.MC" type m ast cells (M irowski el aI, 1990) . Arguably, the am or-
phous granul e subcompartments o bserved in the majority of the 
cells could represent chymctse-containing granule domain s rather 
than suboptimally preserved tryptase domains , but the mast ce lls 
were chymase-negative by light microscopy and showed other 
ultrastructural characte ri stics of MCT celis, including the presence 
of rope- like granul es and heterogen eity of granule solubili zation. 
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Figure 2. Most splcnic mast cclls cxpn!Ss tryptasc but not chymasc. (aJ II1111lunoa ikalinc phosphawse staining idcnrifi cs imll1unoreactivc tryptasc in 
tbe llJajority of the mast ce ll s of the spleen (nuclcar f.'Sr. red countcrsw il) ; srn/c' bM. 1110 /10111). Note the association of the bluc-gra y reaction produce with the 
spindled mast cells. (b) Staining for iml11unoreactive ch Yll1asc shows on ly a few sca ttered positive Illast: cells. scve ra] o f which arc marked with - (nuclear 
filSt red coulltcrstain; srnle bnr. 1 ()(J /10111) . 
Therefore, the ultrastructural morphol ogy of these cell s supports 
the interpretatio n that M C T werc prescnt in the splcnic inftltrate. 
Tryptase and chY!11ase are both serine endoproteases; the former 
has specificity for trypsin-like substrates (Schwartz Cf a[, 1981. ), and 
the latter has specificity for chymotrypsin-like substrates (Schechter 
ef ai , 1986). Most anato mic sites contain a mixture of MC T and 
MCc r , but MCe T predominate in the skin, breast p,lrenchyma, 
ax illary lymph nodes , and bowel submucosa, and M C T predomi-
nate in the lung and bowe l mucosa (Craig e( ai, 1988; W eidner and 
Austen , ·}990). M ast celts are rare in norn1,)1 splenic ti ssuc, and we 
are not aware of reports of a predominant phenotype associated 
with that organ . Because our results ~rc derived £i'om the study of 
splenic tissue derived from a singl e patient, they may no t be 
relevant to other m astocytos is patients with splenic involvem ent or 
to normal splenic mas t cells. In addition to cbymase, MC .T contain 
proteases that are not found ill M CT , and these two types of mast 
ce ll s show differential activati on by various biologi c m echanism s 
and diffe rential inhibition by drugs such as cromolyn (Gall i, 1990; 
Schwartz, 1993). It bas been suggested , therefore, that the two 
different mast cell subtypes may h ave signiti canrly different func-
tional roles and responses to therapellti c interven tion . 
In gen eral, ma st cell heterogeneity co uld represent th e presence 
of separate sublin eages or sllbclones of mast cells that have different 
phen o typi c chara cteristics and th at mi grate to different ,matolni c 
locations. Alternarively, he terogene ity co uld be secondary to the 
inAll ence of the mkroenvironrn ent 011 ma st ce ll phenotype. Studies 
of murine mast ce ll s suppOrt the preeminence of mi cro ell viI' on me 11-
tal inAucn ccs on mast ce ll ph enotype (Ga lli e ( a[. 1982; Nakano e{ a[, 
1985; Galli. 1990; T sai rr (1[, '1991). These studic s show that. 
depending o n their localizatio n ill "ill" , clonaJly deri ved mase ceUs 
and/or their progeny are able to acquire characteristics of bodl 
"connective ti ssuc type mast ce lls" o r "mucosal type mast cells." 
two murine m ast ce ll types that are analogous but not identic;\! tQ 
human M Ce T and M C'r , respectively, when inj ected into ma { 
cell-d e tlcient mi ce (Ga lli ef cl[. 1982; Nakano ef nl, 1985; Galli. 
1990; Tsai CI (1/ , 1991). IGt ligand is prod uced by fibrobl asts, 
endo thelial cells, and keratinocytes and circulates at relatively high 
levels and th erefore is present in most ti ssues (Flanagan and Leder, 
1990; Langley CI a/, 1993; Longley el ai, 1993; Weiss d ai, 1995). 
Injection of pharmacologic doses of kit ligand into rodents induces 
the accumul ation o f both types of mast cells ill an anatomic 
distribution similar to t1U1t observed for mast cells in normal 
rodents, also suggestin g that kit ligand stimulation does nor pret: 
erentially inAuen ce the development of different mature mast ceU 
phenotypes. Ollr d.)ta do no t a llo w LIS to reso lve this "narure" IlersllS 
"nurture" quandary with respect to mast ce ll hete rogeneity iu 
humans because it is possibl e that a separate subclone of mast cells 
lacking ch )'mase expression migrated prefercl1ti"lly to the spleen. 
Our obse rva tio ns do offer insight. however, into the effe cts of 
Figurc 3. Dcrmal mast cclls cxpress both tryptasc and ch Yl113sc. (II) Bille-gra y alkaline phosphatas~ reaction pruduct lndi cil tcs that lllost o f the masl 
cc l1 s infilcfHtin g the skin express ;nlJ111111 0 rCaCtl vc tryptase (nuclear fast r~d coun terstain: :iftll" bar. 50 /J. 111). (b) A 5il11il:lr patterll o f ill1l1\ull o reacti,'c chy-mase 
illdicates that most o f the cuta neous mast cells also expt·css this protein (nuclear fast rcd coulltcrstain ; Sf ll/" IJaf. 50 1~11l ) · 
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Figure 4. Splenic mast cells contain granules with ultrastructural 
features of " tryptasc only" granules. Electro n Inicroscopy of 111<l St ce ll 
granu le morphology li'om in vo lved spleen . T he predominallt granul e 
phenotypes consisted of scro ll s cu t in trall svc rse p lane I (A) -->J. and 
longirudinal plane [ (B) and (0). ->1 juxtaposed w ith am orph ous. variably 
electron-dense matri x. Occasio nal granule, arc largely composed of bo th 
poorly fo rllled and well-fo nned scro ll s (C). A spectrum of gra nule substruc-
tures r a nging ti'o lll slnalier granules w ith d iscrete sn o ll (-» and am o rpho us 
regions I (0) and (E) I to larger granules with less di sti nct clectron-Iuce llt 
matrices [ (F) and (G) I and ro pe-like confi gurati ons (I-l) suggest so lubil iza-
tion a nd degranulatio n . SCIlIe fltl/ 's, (A)-(C) 0. 1 J.un: (0). (E). and (H) 0.2 
J.lm : and (J') and (G) 0.4 J.L111 . 
chron ic ill II i"" sti l11ul ation of human mast ce lls Via the KIT-ki t 
ligand axis. 
We arc una wa re oran y other reports describin g the phenotype of 
human clona ll y derived mast ce ll s in different tissue microen viron-
ments. Our identifi ca ti on of a somatic point mutation of c-KiT in 
th is patient (Longley cl 111, 1996) provided us with a convenient 
marker for hi s neoplastic mast ce lls and allowed us to document 
heterogeneity o f chyma se expression by mast ce lls of the same 
clone in different an atomic loca tions. T he point mutation in thi s 
parient has been shown to ca use constitutive phosphory la ti o ~1 and 
acrivation of KIT and to induce ligand-independen t prohferanon of 
cells ill lIil /'O (Furitsu CI nl. 1993; Tsujimura el nl. 1994). Further-
more, the constituti ve activa tion o f KlT res ulting from this muta-
tion can transform a murine pro-B eype Ba/ F3 cell Line so that it 
behaves aggress ively ill I'i"" (Tsujimura cl nl , 1 99 ~) . Given the 
known ability of act ivated KIT to stimulate mast ce ll proliferation 
and our demonstration of its ill Ilillo association with mast cells, it 
appears likely that this mutation ca used mastocytos is in this patient 
and that these mast ce lls arc clu'onicall y stimulated via KIT. 
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Figure 5. Mast cell s are heterozygous for a n activating c-KIT 
mutation. Com pa rison of cDNA seq uences (bases 2~6~-2-(72) showing 
\\~Jd rype c-KIT (ft:/i fO il I' lanes) and Illutated c-KIT (r(~h' lo ur lanes). Note 
A ~ T transiti o n llIutatio n at base 2468 in the llIu tated c-KIT seq uence. 
The lIIidd fe fu ur iall es show both A allo T at positio ll 2-168. indicating 
produ cts of nOl'I1I,,1 and l11utated ,!l icks present in approxi m ately eq ual 
amounts. 
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T he influ ence of the KIT-kit Li gan d axis on human mast cell 
heterogeneity has not been determined il( lIillll (Geissler c l nl. 1988; 
Anderson CI nl. 1990; Huang el nf. 1990; Williams CI nl, 1990; Zsebo 
CI n/1990). Human m ast cells and their CD34+ precursors express 
KIT, and m ast cells develop ill (,itro from kit ligand-s timulated 
CD34 + bone marrow and peripheral blood cells (Kirshenbaum CI nl 
1991, 1992; Mitsui cl nl, 1993). III Ililro . these ki t ligand-stimul ated 
cultured human mast cells express tryptase but do not express 
chymase unless other factors are introduced into the culture system 
(Kirshenbaum el nl, 1992; Mitsui CI nl, 1993). suggesting tha t KIT 
ac tivation m ay be permissive but not directive w ith regard to m ast 
ce ll phenotype. In our patient. both the dermal MCe T and the 
splenic MCT express constitutively activa ted KIT protein but 
differentially express chymase, enabling us to concl ude that ill "i"" 
chronic stimulation by KlT did not irrevocably cOl11mit human mast 
cells to o ne or the o ther lineage in this case. T hu s, aldlOugh the kit 
ligand-KlT axis may stimulate proliferation of ma st cells and all ow 
tbeir diffe renti ation , it appears un likely that it directs that differen-
tiation alo ng a particular pathwa y. 
This ,.,'scnrch 'I'ns Ji llldl'd by iVIAMS Gmll 's P3()AR~19~2 " li d N IH Gra ll' 
R29A R~0514. 
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